APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pomalidomide

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pomalidomide Industry Growth and Trends Forecast to 2032

23 December 2025108 pages

Choose your research edition.

Industry ResearchPomalidomide Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Pomalidomide Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Pomalidomide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pomalidomide Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Pomalidomide Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Pomalidomide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pomalidomide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pomalidomide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pomalidomide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pomalidomide include Celgene, Chia Tai-Tianqing, Cipla, Dr Reddy's Laboratories, Hanson Pharm, Indiabulls pharmaceutical, Intas Pharmaceuticals, Meidakang Huakang Pharmaceutical and Natco Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pomalidomide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pomalidomide market size, estimates, and forecasts are presented in terms of sales volume (k pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pomalidomide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pomalidomide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pomalidomide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pomalidomide Market by Company

Celgene

Chia Tai-Tianqing

Cipla

Dr Reddy's Laboratories

Hanson Pharm

Indiabulls pharmaceutical

Intas Pharmaceuticals

Meidakang Huakang Pharmaceutical

Natco Pharma

SL PHARM

Glenmark Pharmaceuticals

Qilu Pharmaceutical

Shandong Kongfu Pharmaceutical

Pomalidomide Segment by Type

1mg Tables

2mg Tables

4mg Tables

Pomalidomide Segment by Application

Clinic

Hospital

Drug Center

Others

Pomalidomide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pomalidomide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pomalidomide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pomalidomide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pomalidomide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pomalidomide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1mg Tables Table 2. Major Company of 2mg Tables Table 3. Major Company of 4mg Tables Table 4. Global Pomalidomide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pomalidomide Sales by Type (2021-2026) & (k pcs) Table 6. Global Pomalidomide Sales Market Share in Volume by Type (2021-2026) Table 7. Global Pomalidomide Sales by Type (2021-2026) & (US$ Million) Table 8. Global Pomalidomide Sales Market Share in Value by Type (2021-2026) Table 9. Global Pomalidomide Price by Type (2021-2026) & (US$/pcs) Table 10. Global Pomalidomide Sales by Type (2027-2032) & (k pcs) Table 11. Global Pomalidomide Sales Market Share in Volume by Type (2027-2032) Table 12. Global Pomalidomide Sales by Type (2027-2032) & (US$ Million) Table 13. Global Pomalidomide Sales Market Share in Value by Type (2027-2032) Table 14. Global Pomalidomide Price by Type (2027-2032) & (US$/pcs) Table 15. North America Pomalidomide Sales by Type (2021-2026) & (k pcs) Table 16. North America Pomalidomide Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Pomalidomide Sales by Type (2021-2026) & (k pcs) Table 18. Europe Pomalidomide Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Pomalidomide Sales by Type (2021-2026) & (k pcs) Table 20. Asia-Pacific Pomalidomide Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Pomalidomide Sales by Type (2021-2026) & (k pcs) Table 22. Latin America Pomalidomide Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Pomalidomide Sales by Type (2021-2026) & (k pcs) Table 24. Middle East and Africa Pomalidomide Sales by Type (2021-2026) & (US$ Million) Table 25. Pomalidomide Industry Trends Table 26. Pomalidomide Industry Drivers Table 27. Pomalidomide Industry Opportunities and Challenges Table 28. Pomalidomide Industry Restraints Table 29. Global Pomalidomide Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Pomalidomide Revenue Market Share by Company (2021-2026) Table 31. Global Pomalidomide Sales by Company (2021-2026) & (k pcs) Table 32. Global Pomalidomide Sales Share by Company (2021-2026) Table 33. Global Pomalidomide Market Price by Company (2021-2026) & (US$/pcs) Table 34. Global Pomalidomide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Pomalidomide Major Company Production Sites and Headquarters Table 36. Global Pomalidomide Company, Product Type & Application Table 37. Global Pomalidomide Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Pomalidomide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Pomalidomide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Pomalidomide Sales by Region (2021-2026) & (k pcs) Table 42. Global Pomalidomide Sales Market Share in Volume by Region (2021-2026) Table 43. Global Pomalidomide Sales by Region (2021-2026) & (US$ Million) Table 44. Global Pomalidomide Sales Market Share in Value by Region (2021-2026) Table 45. Global Pomalidomide Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 46. Global Pomalidomide Sales by Region (2027-2032) & (k pcs) Table 47. Global Pomalidomide Sales Market Share in Volume by Region (2027-2032) Table 48. Global Pomalidomide Sales by Region (2027-2032) & (US$ Million) Table 49. Global Pomalidomide Sales Market Share in Value by Region (2027-2032) Table 50. Global Pomalidomide Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2027-2032) Table 51. Global Pomalidomide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Pomalidomide Sales by Application (2021-2026) & (k pcs) Table 53. Global Pomalidomide Sales Market Share in Volume by Application (2021-2026) Table 54. Global Pomalidomide Sales by Application (2021-2026) & (US$ Million) Table 55. Global Pomalidomide Sales Market Share in Value by Application (2021-2026) Table 56. Global Pomalidomide Price by Application (2021-2026) & (US$/pcs) Table 57. Global Pomalidomide Sales by Application (2027-2032) & (k pcs) Table 58. Global Pomalidomide Sales Market Share in Volume by Application (2027-2032) Table 59. Global Pomalidomide Sales by Application (2027-2032) & (US$ Million) Table 60. Global Pomalidomide Sales Market Share in Value by Application (2027-2032) Table 61. Global Pomalidomide Price by Application (2027-2032) & (US$/pcs) Table 62. North America Pomalidomide Sales by Application (2021-2026) & (k pcs) Table 63. North America Pomalidomide Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Pomalidomide Sales by Application (2021-2026) & (k pcs) Table 65. Europe Pomalidomide Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Pomalidomide Sales by Application (2021-2026) & (k pcs) Table 67. Asia-Pacific Pomalidomide Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Pomalidomide Sales by Application (2021-2026) & (k pcs) Table 69. Latin America Pomalidomide Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Pomalidomide Sales by Application (2021-2026) & (k pcs) Table 71. Middle East and Africa Pomalidomide Sales by Application (2021-2026) & (US$ Million) Table 72. Celgene Company Information Table 73. Celgene Business Overview Table 74. Celgene Pomalidomide Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 75. Celgene Pomalidomide Product Portfolio Table 76. Celgene Recent Development Table 77. Chia Tai-Tianqing Company Information Table 78. Chia Tai-Tianqing Business Overview Table 79. Chia Tai-Tianqing Pomalidomide Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 80. Chia Tai-Tianqing Pomalidomide Product Portfolio Table 81. Chia Tai-Tianqing Recent Development Table 82. Cipla Company Information Table 83. Cipla Business Overview Table 84. Cipla Pomalidomide Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 85. Cipla Pomalidomide Product Portfolio Table 86. Cipla Recent Development Table 87. Dr Reddy's Laboratories Company Information Table 88. Dr Reddy's Laboratories Business Overview Table 89. Dr Reddy's Laboratories Pomalidomide Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 90. Dr Reddy's Laboratories Pomalidomide Product Portfolio Table 91. Dr Reddy's Laboratories Recent Development Table 92. Hanson Pharm Company Information Table 93. Hanson Pharm Business Overview Table 94. Hanson Pharm Pomalidomide Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 95. Hanson Pharm Pomalidomide Product Portfolio Table 96. Hanson Pharm Recent Development Table 97. Indiabulls pharmaceutical Company Information Table 98. Indiabulls pharmaceutical Business Overview Table 99. Indiabulls pharmaceutical Pomalidomide Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 100. Indiabulls pharmaceutical Pomalidomide Product Portfolio Table 101. Indiabulls pharmaceutical Recent Development Table 102. Intas Pharmaceuticals Company Information Table 103. Intas Pharmaceuticals Business Overview Table 104. Intas Pharmaceuticals Pomalidomide Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 105. Intas Pharmaceuticals Pomalidomide Product Portfolio Table 106. Intas Pharmaceuticals Recent Development Table 107. Meidakang Huakang Pharmaceutical Company Information Table 108. Meidakang Huakang Pharmaceutical Business Overview Table 109. Meidakang Huakang Pharmaceutical Pomalidomide Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 110. Meidakang Huakang Pharmaceutical Pomalidomide Product Portfolio Table 111. Meidakang Huakang Pharmaceutical Recent Development Table 112. Natco Pharma Company Information Table 113. Natco Pharma Business Overview Table 114. Natco Pharma Pomalidomide Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 115. Natco Pharma Pomalidomide Product Portfolio Table 116. Natco Pharma Recent Development Table 117. SL PHARM Company Information Table 118. SL PHARM Business Overview Table 119. SL PHARM Pomalidomide Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 120. SL PHARM Pomalidomide Product Portfolio Table 121. SL PHARM Recent Development Table 122. Glenmark Pharmaceuticals Company Information Table 123. Glenmark Pharmaceuticals Business Overview Table 124. Glenmark Pharmaceuticals Pomalidomide Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 125. Glenmark Pharmaceuticals Pomalidomide Product Portfolio Table 126. Glenmark Pharmaceuticals Recent Development Table 127. Qilu Pharmaceutical Company Information Table 128. Qilu Pharmaceutical Business Overview Table 129. Qilu Pharmaceutical Pomalidomide Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 130. Qilu Pharmaceutical Pomalidomide Product Portfolio Table 131. Qilu Pharmaceutical Recent Development Table 132. Shandong Kongfu Pharmaceutical Company Information Table 133. Shandong Kongfu Pharmaceutical Business Overview Table 134. Shandong Kongfu Pharmaceutical Pomalidomide Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 135. Shandong Kongfu Pharmaceutical Pomalidomide Product Portfolio Table 136. Shandong Kongfu Pharmaceutical Recent Development Table 137. North America Pomalidomide Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 138. North America Pomalidomide Sales by Country (2021-2026) & (k pcs) Table 139. North America Pomalidomide Sales Market Share by Country (2021-2026) Table 140. North America Pomalidomide Sales Forecast by Country (2027-2032) & (k pcs) Table 141. North America Pomalidomide Sales Market Share Forecast by Country (2027-2032) Table 142. North America Pomalidomide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Pomalidomide Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Pomalidomide Market Share by Country (2021-2026) Table 145. North America Pomalidomide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Pomalidomide Market Share Forecast by Country (2027-2032) Table 147. Europe Pomalidomide Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 148. Europe Pomalidomide Sales by Country (2021-2026) & (k pcs) Table 149. Europe Pomalidomide Sales Market Share by Country (2021-2026) Table 150. Europe Pomalidomide Sales Forecast by Country (2027-2032) & (k pcs) Table 151. Europe Pomalidomide Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Pomalidomide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Pomalidomide Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Pomalidomide Market Share by Country (2021-2026) Table 155. Europe Pomalidomide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Pomalidomide Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Pomalidomide Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Pomalidomide Sales by Country (2021-2026) & (k pcs) Table 159. Asia-Pacific Pomalidomide Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Pomalidomide Sales Forecast by Country (2027-2032) & (k pcs) Table 161. Asia-Pacific Pomalidomide Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Pomalidomide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Pomalidomide Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Pomalidomide Market Share by Country (2021-2026) Table 165. Asia-Pacific Pomalidomide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Pomalidomide Market Share Forecast by Country (2027-2032) Table 167. Latin America Pomalidomide Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 168. Latin America Pomalidomide Sales by Country (2021-2026) & (k pcs) Table 169. Latin America Pomalidomide Sales Market Share by Country (2021-2026) Table 170. Latin America Pomalidomide Sales Forecast by Country (2027-2032) & (k pcs) Table 171. Latin America Pomalidomide Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Pomalidomide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Pomalidomide Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Pomalidomide Market Share by Country (2021-2026) Table 175. Latin America Pomalidomide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Pomalidomide Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Pomalidomide Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Pomalidomide Sales by Country (2021-2026) & (k pcs) Table 179. Middle East and Africa Pomalidomide Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Pomalidomide Sales Forecast by Country (2027-2032) & (k pcs) Table 181. Middle East and Africa Pomalidomide Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Pomalidomide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Pomalidomide Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Pomalidomide Market Share by Country (2021-2026) Table 185. Middle East and Africa Pomalidomide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Pomalidomide Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Pomalidomide Distributors List Table 190. Pomalidomide Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Pomalidomide Image Figure 2. Global Pomalidomide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pomalidomide Market Size (2021-2032) & (US$ Million) Figure 4. Global Pomalidomide Sales (2021-2032) & (k pcs) Figure 5. 1mg Tables Image Figure 6. Global 1mg Tables Sales YoY Growth (2021-2032) & (k pcs) Figure 7. 2mg Tables Image Figure 8. Global 2mg Tables Sales YoY Growth (2021-2032) & (k pcs) Figure 9. 4mg Tables Image Figure 10. Global 4mg Tables Sales YoY Growth (2021-2032) & (k pcs) Figure 11. Global Pomalidomide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Pomalidomide Market Share by Type 2025 VS 2032 Figure 13. North America Pomalidomide Sales Market Share in Volume by Type in 2025 Figure 14. North America Pomalidomide Sales Market Share in Value by Type in 2025 Figure 15. Europe Pomalidomide Sales Market Share in Volume by Type in 2025 Figure 16. Europe Pomalidomide Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Pomalidomide Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Pomalidomide Sales Market Share in Value by Type in 2025 Figure 19. Latin America Pomalidomide Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Pomalidomide Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Pomalidomide Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Pomalidomide Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Pomalidomide Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k pcs) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (k pcs) Figure 29. Drug Center Image Figure 30. Global Drug Center Sales YoY Growth (2021-2032) & (k pcs) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k pcs) Figure 33. Global Pomalidomide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Pomalidomide Market Share by Application 2025 VS 2032 Figure 35. North America Pomalidomide Sales Market Share in Volume by Application in 2025 Figure 36. North America Pomalidomide Sales Market Share in Value by Application in 2025 Figure 37. Europe Pomalidomide Sales Market Share in Volume by Application in 2025 Figure 38. Europe Pomalidomide Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Pomalidomide Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Pomalidomide Sales Market Share in Value by Application in 2025 Figure 41. Latin America Pomalidomide Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Pomalidomide Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Pomalidomide Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Pomalidomide Sales Market Share in Value by Application in 2025 Figure 45. North America Pomalidomide Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 46. North America Pomalidomide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Pomalidomide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Pomalidomide Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pomalidomide Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 50. Europe Pomalidomide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Pomalidomide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Pomalidomide Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pomalidomide Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 54. Asia-Pacific Pomalidomide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Pomalidomide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Pomalidomide Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pomalidomide Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 58. Latin America Pomalidomide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Pomalidomide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Pomalidomide Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pomalidomide Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 62. Middle East and Africa Pomalidomide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Pomalidomide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Pomalidomide Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Pomalidomide Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Pomalidomide Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg Tables
  • 2mg Tables
  • 4mg Tables
Applications
  • Clinic
  • Hospital
  • Drug Center
  • Others
Companies covered
  • Celgene
  • Chia Tai-Tianqing
  • Cipla
  • Dr Reddy's Laboratories
  • Hanson Pharm
  • Indiabulls pharmaceutical
  • Intas Pharmaceuticals
  • Meidakang Huakang Pharmaceutical
  • Natco Pharma
  • SL PHARM
  • Glenmark Pharmaceuticals
  • Qilu Pharmaceutical
  • Shandong Kongfu Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pomalidomide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pomalidomide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pomalidomide Market by Type
  6. 1.3.1 1mg Tables
  7. 1.3.2 2mg Tables
  8. 1.3.3 4mg Tables
  9. 1.4 Global Pomalidomide Market Size by Type
  10. 1.4.1 Global Pomalidomide Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Pomalidomide Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Pomalidomide Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Pomalidomide Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Pomalidomide Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Pomalidomide Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Pomalidomide Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Pomalidomide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pomalidomide Industry Trends
  2. 2.2 Pomalidomide Industry Drivers
  3. 2.3 Pomalidomide Industry Opportunities and Challenges
  4. 2.4 Pomalidomide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pomalidomide Revenue (2021-2026)
  2. 3.2 Global Top Players by Pomalidomide Sales (2021-2026)
  3. 3.3 Global Top Players by Pomalidomide Price (2021-2026)
  4. 3.4 Global Pomalidomide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pomalidomide Major Company Production Sites & Headquarters
  6. 3.6 Global Pomalidomide Company, Product Type & Application
  7. 3.7 Global Pomalidomide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pomalidomide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pomalidomide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pomalidomide Tier 1, Tier 2, and Tier 3
4 Pomalidomide Regional Status and Outlook
  1. 4.1 Global Pomalidomide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pomalidomide Historic Market Size by Region
  3. 4.2.1 Global Pomalidomide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pomalidomide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pomalidomide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pomalidomide Forecasted Market Size by Region
  7. 4.3.1 Global Pomalidomide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pomalidomide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pomalidomide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pomalidomide by Application
  1. 5.1 Pomalidomide Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Drug Center
  5. 5.1.4 Others
  6. 5.2 Global Pomalidomide Market Size by Application
  7. 5.2.1 Global Pomalidomide Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Pomalidomide Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Pomalidomide Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Pomalidomide Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Pomalidomide Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Pomalidomide Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Pomalidomide Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Pomalidomide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Celgene
  2. 6.1.1 Celgene Company Information
  3. 6.1.2 Celgene Business Overview
  4. 6.1.3 Celgene Pomalidomide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Celgene Pomalidomide Product Portfolio
  6. 6.1.5 Celgene Recent Developments
  7. 6.2 Chia Tai-Tianqing
  8. 6.2.1 Chia Tai-Tianqing Company Information
  9. 6.2.2 Chia Tai-Tianqing Business Overview
  10. 6.2.3 Chia Tai-Tianqing Pomalidomide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Chia Tai-Tianqing Pomalidomide Product Portfolio
  12. 6.2.5 Chia Tai-Tianqing Recent Developments
  13. 6.3 Cipla
  14. 6.3.1 Cipla Company Information
  15. 6.3.2 Cipla Business Overview
  16. 6.3.3 Cipla Pomalidomide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cipla Pomalidomide Product Portfolio
  18. 6.3.5 Cipla Recent Developments
  19. 6.4 Dr Reddy's Laboratories
  20. 6.4.1 Dr Reddy's Laboratories Company Information
  21. 6.4.2 Dr Reddy's Laboratories Business Overview
  22. 6.4.3 Dr Reddy's Laboratories Pomalidomide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Dr Reddy's Laboratories Pomalidomide Product Portfolio
  24. 6.4.5 Dr Reddy's Laboratories Recent Developments
  25. 6.5 Hanson Pharm
  26. 6.5.1 Hanson Pharm Company Information
  27. 6.5.2 Hanson Pharm Business Overview
  28. 6.5.3 Hanson Pharm Pomalidomide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hanson Pharm Pomalidomide Product Portfolio
  30. 6.5.5 Hanson Pharm Recent Developments
  31. 6.6 Indiabulls pharmaceutical
  32. 6.6.1 Indiabulls pharmaceutical Company Information
  33. 6.6.2 Indiabulls pharmaceutical Business Overview
  34. 6.6.3 Indiabulls pharmaceutical Pomalidomide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Indiabulls pharmaceutical Pomalidomide Product Portfolio
  36. 6.6.5 Indiabulls pharmaceutical Recent Developments
  37. 6.7 Intas Pharmaceuticals
  38. 6.7.1 Intas Pharmaceuticals Company Information
  39. 6.7.2 Intas Pharmaceuticals Business Overview
  40. 6.7.3 Intas Pharmaceuticals Pomalidomide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Intas Pharmaceuticals Pomalidomide Product Portfolio
  42. 6.7.5 Intas Pharmaceuticals Recent Developments
  43. 6.8 Meidakang Huakang Pharmaceutical
  44. 6.8.1 Meidakang Huakang Pharmaceutical Company Information
  45. 6.8.2 Meidakang Huakang Pharmaceutical Business Overview
  46. 6.8.3 Meidakang Huakang Pharmaceutical Pomalidomide Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Meidakang Huakang Pharmaceutical Pomalidomide Product Portfolio
  48. 6.8.5 Meidakang Huakang Pharmaceutical Recent Developments
  49. 6.9 Natco Pharma
  50. 6.9.1 Natco Pharma Company Information
  51. 6.9.2 Natco Pharma Business Overview
  52. 6.9.3 Natco Pharma Pomalidomide Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Natco Pharma Pomalidomide Product Portfolio
  54. 6.9.5 Natco Pharma Recent Developments
  55. 6.10 SL PHARM
  56. 6.10.1 SL PHARM Company Information
  57. 6.10.2 SL PHARM Business Overview
  58. 6.10.3 SL PHARM Pomalidomide Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 SL PHARM Pomalidomide Product Portfolio
  60. 6.10.5 SL PHARM Recent Developments
  61. 6.11 Glenmark Pharmaceuticals
  62. 6.11.1 Glenmark Pharmaceuticals Company Information
  63. 6.11.2 Glenmark Pharmaceuticals Business Overview
  64. 6.11.3 Glenmark Pharmaceuticals Pomalidomide Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Glenmark Pharmaceuticals Pomalidomide Product Portfolio
  66. 6.11.5 Glenmark Pharmaceuticals Recent Developments
  67. 6.12 Qilu Pharmaceutical
  68. 6.12.1 Qilu Pharmaceutical Company Information
  69. 6.12.2 Qilu Pharmaceutical Business Overview
  70. 6.12.3 Qilu Pharmaceutical Pomalidomide Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Qilu Pharmaceutical Pomalidomide Product Portfolio
  72. 6.12.5 Qilu Pharmaceutical Recent Developments
  73. 6.13 Shandong Kongfu Pharmaceutical
  74. 6.13.1 Shandong Kongfu Pharmaceutical Company Information
  75. 6.13.2 Shandong Kongfu Pharmaceutical Business Overview
  76. 6.13.3 Shandong Kongfu Pharmaceutical Pomalidomide Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Shandong Kongfu Pharmaceutical Pomalidomide Product Portfolio
  78. 6.13.5 Shandong Kongfu Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Pomalidomide Sales by Country
  2. 7.1.1 North America Pomalidomide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pomalidomide Sales by Country (2021-2026)
  4. 7.1.3 North America Pomalidomide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pomalidomide Market Size by Country
  6. 7.2.1 North America Pomalidomide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pomalidomide Market Size by Country (2021-2026)
  8. 7.2.3 North America Pomalidomide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pomalidomide Sales by Country
  2. 8.1.1 Europe Pomalidomide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pomalidomide Sales by Country (2021-2026)
  4. 8.1.3 Europe Pomalidomide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pomalidomide Market Size by Country
  6. 8.2.1 Europe Pomalidomide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pomalidomide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pomalidomide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pomalidomide Sales by Country
  2. 9.1.1 Asia-Pacific Pomalidomide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pomalidomide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pomalidomide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pomalidomide Market Size by Country
  6. 9.2.1 Asia-Pacific Pomalidomide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pomalidomide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pomalidomide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pomalidomide Sales by Country
  2. 10.1.1 South America Pomalidomide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pomalidomide Sales by Country (2021-2026)
  4. 10.1.3 South America Pomalidomide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pomalidomide Market Size by Country
  6. 10.2.1 South America Pomalidomide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pomalidomide Market Size by Country (2021-2026)
  8. 10.2.3 South America Pomalidomide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pomalidomide Sales by Country
  2. 11.1.1 Middle East and Africa Pomalidomide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pomalidomide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pomalidomide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pomalidomide Market Size by Country
  6. 11.2.1 Middle East and Africa Pomalidomide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pomalidomide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pomalidomide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pomalidomide Value Chain Analysis
  2. 12.1.1 Pomalidomide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pomalidomide Production Mode & Process
  7. 12.2 Pomalidomide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pomalidomide Distributors
  10. 12.2.3 Pomalidomide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst